News about Global Pharma

Unicon Pharma Partners with VRR Life Sciences to Expand Global CSV Capabilities

Unicon Pharma has partnered with Bengaluru-based VRR Life Sciences to expand global computer system validation (CSV) services and drive digital transformation in the life sciences industry.

Global Pharma | 27/05/2025 | By Manvi |  454

Zylox-Tonbridge Secures First International Approval for Vascular Device in Indonesia

Zylox-Tonbridge Medical Technology Co., Ltd. announced that its proprietary ZYLOX Unicorn™ Vascular Closure Device (VCD) has received regulatory approval in Indonesia. This marks the ZYLOX Unicorn™ Vascular Closure Device's first international market clearance and the Company's first market authorization in Southeast Asia.

Global Pharma | 27/05/2025 | By Manvi |  223

Delta Development's Blood Coolers Set New Standard for Prehospital Care Across US

Delta Development Team (DDT) announce that its innovative APRU 6L portable blood refrigerator and Delta ICE 2L Smart Blood Cooler are setting a national benchmark for prehospital blood storage and transport, revolutionizing healthcare on both the West and East coasts, helping emergency services deliver life-saving care from California to New Jersey.

Global Pharma | 27/05/2025 | By Manvi |  170

Mindray Launches BeneVision V Series at Euroanaesthesia 2025 in Lisbon

Mindray launched its BeneVision V Series patient monitoring solution at Euroanaesthesia 2025 in Lisbon.

Global Pharma | 26/05/2025 | By Manvi |  403

Esaote Debuts MyLabHeron Ultrasound at SCIVAC Congress in Rimini

MyLab™Heron is the latest result of Esaote's research activity in high-performance portable ultrasound systems, in which the Company has now been recognized for over 30 years and where it stands out for its comprehensive product portfolio and innovative solutions.

Global Pharma | 26/05/2025 | By Manvi |  118

Relief Therapeutics Receives FDA Rare Pediatric Disease Designation for RLF-TD011

US Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation to RLF-TD011 for the treatment of epidermolysis bullosa (EB).

Global Pharma | 26/05/2025 | By Manvi |  205

US FDA Approves Use of Nucala (Mepolizumab) to Treat COPD in Adults

The US Food and Drug Administration (FDA) has approved Nucala (mepolizumab) from GSK plc. as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic phenotype.

Global Pharma | 26/05/2025 | By Manvi |  296

InnoCare Secures China's NMPA Approval for Minjuvi Combo in Treating Relapsed DLBCL

InnoCare Pharma has received China National Medical Products Administration (NMPA) approval for Minjuvi (tafasitamab) plus lenalidomide to treat adult patients with relapsed or refractory DLBCL in China who are ineligible for stem cell transplant.

Global Pharma | 23/05/2025 | By Manvi |  323

NextCell and Fujifilm Irvine Scientific Enter Strategic Pact

The collaboration between NextCell Pharma and Fujifilm Irvine Scientific Inc. will bring together their core expertise in mesenchymal stromal cells (MSCs) and raw materials for the life science sector.

Global Pharma | 23/05/2025 | By Manvi |  213

Venus Remedies Secures Ukrainian GNP Renewal for Baddi Facility

Venus Remedies aims to strengthen its global pharmaceutical presence after the renewal of GMP certification from Ukraine's State Service on Medicines and Drugs Control (SMDC) for its Unit-II manufacturing facility located in Baddi, Himachal Pradesh.

Global Pharma | 23/05/2025 | By Manvi |  442